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Characterization of Protein Involved in Hemolysis Expressed by 
Sneathia amnii, a Pathogen of the Female Urogenital Tract 
Gabriella L. Gentile, Lizette I. Carrasco, Amy Stanford, Kimberly K. Jefferson, PhD. 
Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University, Richmond VA 
Sneathia amnii is a poorly characterized gram-negative anaerobe 
that commonly colonizes the vagina. It has been linked to many 
obstetric disorders, including preterm labor, preeclampsia, and 
chorioamnionitis. S. amnii lyses human red blood cells, and we aimed 
to identify the hemolysin. We identified two genes that appear to 
encode transporter and effector components of a two-partner 
secretion system. The putative effector, which we refer to as SaFHA, 
contains a domain with amino acid similarity to the filamentous 
hemagglutinin (FHA) of Bordetella pertussis and its predicted 
structure suggests it may form a transmembrane channel or pore. 
Thus, we hypothesized that SaFHA would be secreted by S. amnii 
and that it would play a role in hemoglobbin release. To test this, a 
portion of the gene encoding the SaFHA protein in S. amnii was 
expressed in E. coli and used as an immunogen in rabbits. Western 
analysis using anti-SaFHA revealed that the protein is secreted and 
localizes to the bacterial surface. Pre-treatment of S. amnii with anti-
SaFHA blocked the hemolytic activity whereas antiserum against an 
irrelevant protein had no effect. We partially purified SaFHA from S. 
amnii using cation exchange chromatography and the partially 
purified protein mediated hemoglobin release from human RBC, 
supporting our hypothesis. Further characterization of SaFHA will 
help provide more insight on the virulence of S. amnii, and perhaps 
shed light on the etiology of Sneathia-associated vaginal conditions, 
as well as future treatment options. 
 
Bioinformatic analysis of Sn35 genome identified 2 genes with amino acid and structural similarity 
to two proteins involved in two-partner type Vb secretion (Tps) system of B. pertussis. 
   
Fig. 9 Agarose gel of 
l i n e a r i z e d D N A 
f r a g m e n t , 
constructed through 
SOE PCR. 1). 1 kb 
DNA ladder, 2). SOE 
PCR product. 
 
What role does SaFHA play in S. amnii? 
Methods 
Scheme for Production of Isogenic saFHA Deletion Mutant  
Thank you to the members of the Jefferson lab, as well as the VCU PREP Program.  
The FHA 
homologue of S. 
amnii plays a role 
in the release of 
hemoglobin from 
human RBC.  
Fig. 1 (A) SEM micrograph of Sneathia 
amnii morphology. (B) S. amnii consists of 
long gram-negative rods and short rods and 
cocci.  
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F i g . 2 S t r u c t u r a l 
c o m p a r i s o n  o f 
transporter proteins in 
S . a m n i i a n d  B . 
pertussis. Left: FhaC 
from B. Pertussis. Right: 
SaFHB from S. amnii  
Fig. 3 General model for two-partner 
system (TPS) secretion. Effector (TpsA) 
transporter (TpsB) proteins are synthesized 
and translocated across the CM via the Sec 
system. Transporter inserts itself into the 
OM forming a β-barrel that mediates the 
secretion of effector protein. Image adapted 
from Mazar, et al. (2007).  
 
Fig. 4 Western blot of outer membrane 
fraction of Sn35. 1). 10-250kDa protein ladder, 
2). Spent medium from first centrifugation step, 
3). S. amnii fraction, 4). Post- French Press 
pellet fraction, 5). Supernatant fraction from 
ultracentrifuge, 6). Outer membrane fraction. 
*SaFHA (~200 kDa) detected in lanes 3, 4, and 
6. SaFHA ~250 kDA. 
Fig. 5 Antiserum inhibition of Sn35 hemolytic 
activity. S. amnii strain Sn35 was pre-treated with either 
PBS, pre-immune rabbit serum, antiserum against 
SaFHA, or antiserum against an irrelevant protein. An 
erythrocyte lysis assay was performed by incubating 
200µL of human erythrocytes with 50µL PBS (negative 
control), 0.1% TWEEN 20 (positive control) or 106 pre-
treated bacteria for 2hr at 37˚C. The cells were removed 
by centrifugation and the absorbance of the supernatant 
at 450 nm was measured.  
 
SaFHA antiserum, but not pre-immune serum or 
antiserum against an irrelevant protein, blocks 
hemolytic activity against human erythrocytes, 
suggesting SaFHA is involved in hemolysis.  
SaFHA is localized to the outer membrane of 
S. amnii.   
SaFHA Upstream SaFHA Downstream CAT Cassette  
Acknowledgements  
SaFHA has a predicted pI of 9.4. Cation exchange was used to purify SaFHA from 
outer membrane extracts of S. amnii. 
In order to characterize the role of the SaFHA in the lysis of 
human red blood cells, an isogenic saFHA mutant of Sn35 will be 
constructed through homologous recombination. This mutant 
strain, in addition to purified protein (explained above), will be 
used in adherence and hemolysis assays to assess the role of 
SaFHA in adherence and hemolysis.  
Fig. 8 Scheme for production of isogenic saFHA 
deletion mutant. A small portion of the upstream and 
downstream region of the gene remains intact, while the 
middle is knocked out and replaced with a CAT antibiotic 
resistance cassette, obtained from E. coli pKD3 plasmid.  
FHA = Effector 
•  Outer membrane-
associated 
filamentous 
hemagglutinin, 
and an adhesin  
FhaC = 
Transporter  
•  β-pore-forming 
protein, located in 
the outer 
membrane 
B. 
pertussis 
SaFHA = Effector 
SaFHB = 
Transporter  
S. amnii 
Purification Schematic of SaFHA Through Affinity Chromatography   Purification Schematic of SaFHA Through Affinity Chromatography  
Fig. 7 Hemolytic activity of SaFHA. 
Purified SaFHA was added to human 
e r y t h r o c y t e s a t  i n c r e a s i n g 
concentrations and allowed to incubate 
for 2 hrs. at 37˚C. Remaining whole 
cells were removed by centrifugation 
and the amount of hemoglobin 
released into the supernatant was 
quantified by measuring absorbance at 
OD450nm. 
Fig. 6 Purification of SaFHA 
using cation exchange. OM 
extracts were suspended in 
20mM Tris pH8 + 0.5% Triton-X, 
sonicated, and filter sterilized. The 
OM was applied to a cation 
exchange column, and passed 
through a series of wash steps. 
Western analysis was performed 
on the flow through from each 
wash step. 1). OM Before filtering, 
2). OM After filtering, 3). OM 
cation flow through, 4). Tris pH 8, 
5). Tris pH 8 + 100mM NaCl, 6). 
Tris pH8 + 200mM NaCl, 7). Tris 
pH 8 + 500mM, 8). Tris pH 8 + 
1M. SaFHA ~250 kDA. 
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